603127 Stock Overview
Provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Joinn Laboratories(China)Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥15.95 |
52 Week High | CN¥29.67 |
52 Week Low | CN¥12.32 |
Beta | 0.49 |
11 Month Change | 19.65% |
3 Month Change | -2.68% |
1 Year Change | -42.50% |
33 Year Change | -79.96% |
5 Year Change | 14.74% |
Change since IPO | 566.83% |
Recent News & Updates
Recent updates
Joinn Laboratories(China)Co.Ltd (SHSE:603127) Is Reducing Its Dividend To CN¥0.16
Jul 28Joinn Laboratories(China)Co.,Ltd. (SHSE:603127) Analysts Just Cut Their EPS Forecasts Substantially
Apr 08There May Be Reason For Hope In Joinn Laboratories(China)Co.Ltd's (SHSE:603127) Disappointing Earnings
Apr 04Shareholder Returns
603127 | CN Life Sciences | CN Market | |
---|---|---|---|
7D | 14.2% | 6.1% | 3.0% |
1Y | -42.5% | -40.2% | -19.9% |
Return vs Industry: 603127 underperformed the CN Life Sciences industry which returned -40.2% over the past year.
Return vs Market: 603127 underperformed the CN Market which returned -19.9% over the past year.
Price Volatility
603127 volatility | |
---|---|
603127 Average Weekly Movement | 6.7% |
Life Sciences Industry Average Movement | 6.1% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 603127 has not had significant price volatility in the past 3 months.
Volatility Over Time: 603127's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 2,510 | Dapeng Gao | www.joinn-lab.com |
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models.
Joinn Laboratories(China)Co.,Ltd. Fundamentals Summary
603127 fundamental statistics | |
---|---|
Market cap | CN¥10.87b |
Earnings (TTM) | -CN¥62.99m |
Revenue (TTM) | CN¥2.33b |
5.1x
P/S Ratio-189.0x
P/E RatioIs 603127 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603127 income statement (TTM) | |
---|---|
Revenue | CN¥2.33b |
Cost of Revenue | CN¥1.43b |
Gross Profit | CN¥897.25m |
Other Expenses | CN¥960.24m |
Earnings | -CN¥62.99m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 31, 2024
Earnings per share (EPS) | -0.084 |
Gross Margin | 38.48% |
Net Profit Margin | -2.70% |
Debt/Equity Ratio | 0% |
How did 603127 perform over the long term?
See historical performance and comparison